Inventor · disambiguated record
Klaus Frueh
Also filed as: FRUEH KLAUS
19 granted patents·10 pending applications·131 citations·filing 1997–2021
94Inventor score
Files withUNIV OREGON HEALTH & SCIENCE18VIR BIOTECHNOLOGY INC3ALZHANOVA DINA1FRUEH KLAUS1MOSES ASHLEE1
Top patents by PatentIndex Score
29 records- 0196US10101329B2CMV glycoproteins and recombinant vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2016·Granted Oct 16, 2018·9 cites·46 claims
- 0293US9783823B2Cytomegalovirus vectors enabling control of T cell targetingUNIV OREGON HEALTH & SCIENCE·Filed 2014·Granted Oct 10, 2017·14 cites·28 claims
- 0393US9249427B2Recombinant HCMV and RHCMV vectors and uses thereofUNIV OREGON HEALTH & SCIENCE·Filed 2012·Granted Feb 2, 2016·24 cites·24 claims
- 0492US9982241B2Recombinant HCMV and RHCMV vectors and uses thereofUNIV OREGON HEALTH & SCIENCE·Filed 2015·Granted May 29, 2018·13 cites·54 claims
- 0591US10688164B2CMV vectors comprising microRNA recognition elementsUNIV OREGON HEALTH & SCIENCE·Filed 2016·Granted Jun 23, 2020·8 cites·23 claims
- 0691US10532099B2Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E moleculesUNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted Jan 14, 2020·8 cites·67 claims
- 0790US10316334B2Cytomegalovirus vectors enabling control of T cell targetingUNIV OREGON HEALTH & SCIENCE·Filed 2017·Granted Jun 11, 2019·4 cites·23 claims
- 0890US9541553B2CMV glycoproteins and recombinant vectorsUNIV OREGON HEALTH & SCIENCE·Filed 2014·Granted Jan 10, 2017·10 cites·36 claims
- 0989US10894078B2HIV vaccines comprising one or more population episensus antigensVIR BIOTECHNOLOGY INC·Filed 2015·Granted Jan 19, 2021·4 cites·26 claims
- 1085US10428118B2Human cytomegalovirus comprising exogenous antigensUNIV OREGON HEALTH & SCIENCE·Filed 2015·Granted Oct 1, 2019·5 cites·20 claims
- 1183US10995121B2Human cytomegalovirus comprising exogenous antigensUNIV OREGON HEALTH & SCIENCE·Filed 2019·Granted May 4, 2021·1 cites·30 claims
- 1281US11091779B2Methods and compositions useful in generating non canonical CD8+ T cell responsesUNIV OREGON HEALTH & SCIENCE·Filed 2020·Granted Aug 17, 2021·1 cites·20 claims
- 1379US9328347B2siRNA useful in the treatment of flavivirus infectionSTEIN DAVID A·Filed 2012·Granted May 3, 2016·2 cites·33 claims
- 1472US11692012B2Human cytomegalovirus comprising exogenous antigensUNIV OREGON HEALTH & SCIENCE·Filed 2021·Granted Jul 4, 2023·0 cites·30 claims
- 1571US11628215B2HIV vaccines comprising one or more population episensus antigensVIR BIOTECHNOLOGY INC·Filed 2020·Granted Apr 18, 2023·0 cites·7 claims
- 1671US11554168B2HIV vaccines comprising one or more population episensus antigensVIR BIOTECHNOLOGY INC·Filed 2020·Granted Jan 17, 2023·0 cites·24 claims
- 1768US11266732B2Recombinant HCMV and RHCMV vectors and uses thereofUNIV OREGON HEALTH & SCIENCE·Filed 2018·Granted Mar 8, 2022·0 cites·10 claims
- 1865US2020140888A1Cytomegalovirus vectors enabling control of t cell targetingUNIV OREGON HEALTH & SCIENCE·Filed 2019·Application pending·0 cites
- 1962US11305015B2Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E moleculesUNIV OREGON HEALTH & SCIENCE·Filed 2019·Granted Apr 19, 2022·0 cites·19 claims
- 2062US2013142823A1Cmv glycoproteins and recombinant vectorsSCIENCE UNIVERSITY OREGON HEALTH AND·Filed 2012·Application pending·0 cites
- 2160US2005100891A1Gene expression profile for KSHV infection and methods for treating sameFiled 2004·Application pending·0 cites
- 2259US6033671AIdentification of human cytomegalovirus genes involved in down-regulation of MHC class I heavy chain expressionORTHO MCNEIL PHARM INC·Filed 1997·Granted Mar 7, 2000·28 cites·5 claims
- 2354US2020368333A1Cmv vectors comprising microrna recognition elementsUNIV OREGON HEALTH & SCIENCE·Filed 2020·Application pending·0 cites
- 2451US2018298404A1Methods and compositions useful in generating non canonical cd8+ t cell responsesUNIV OREGON HEALTH & SCIENCE·Filed 2016·Application pending·0 cites
- 2549US2023272036A1Multi-specific t cell receptorsUNIV OREGON HEALTH & SCIENCE·Filed 2020·Application pending·0 cites
- 2648US2003191048A1Gene expression profile for KSHV infection and methods for treating sameFiled 2001·Application pending·0 cites
- 2748US2014335115A1Suppressors of mature t cellsALZHANOVA DINA·Filed 2014·Application pending·0 cites
- 2845US2013345152A1Compositions comprising recombinant cowpox virus protein cpxv014FRUEH KLAUS·Filed 2013·Application pending·0 cites
- 2941US2007072209A1Methods of treatment and diagnosis of Kaposi's sarcoma (KS) and KS related diseasesMOSES ASHLEE·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Klaus Frueh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →